Now, it is the fourth largest segment in non-surgical aesthetics that the company tracks
If your results show reduced receptor sensitivity or appetite-regulation variants, prescription GLP-1 therapy becomes more predictive of success
Change history 01 June 2024 A Correction to this paper has been published: Abbreviations ADA: American Diabetes Association BMI: Body Mass Index CKD: Chronic kidney disease eGFR: Estimated glomerular filtration rate FPG: Fasting plasma glucose GLP-1RAs: Glucagon-like peptide-1 receptor agonists GRADE: Grading of Recommendations, Assessment, Development and Evaluation JBI: Joanna Briggs Institute LDL-C: Lipoprotein cholesterol MACE: Major Adverse Cardiovascular Events RCTs: Randomized controlled trials SGLT2is: Sodiumglucose transport protein 2 inhibitors SBP: Systolic blood pressure T2DM: Type 2 diabetes mellitus MD: Mean difference OR: Odds ratio References Ma C-X, Ma X-N, Guan C-H, Li Y-D, Mauricio D, Fu S-B
Mansur RB, Brietzke E, McIntyre RS
Drug addition was cumulatively or non-cumulative as described in the figure legend